• Six patients with mycosis fungoides were treated with topical mechlorethamine hydrochloride for periods of two to four years. Clinical and histological studies for radiomimetic and radiodermatitis-like effects failed to demonstrate any abnormalities. The only observed changes were generalized hyperpigmentation of the skin and melanin-containing melanophages in the papillary dermis. We consider that the long-term use of topical mechlorethamine may be a safe form of therapy, but that a continuous indefinite follow-up of patients on this medication should be mandatory.
(Arch Dermatol 113:1387-1389, 1977)
Price NM. Topical Mechlorethamine: Cutaneous Changes in Patients With Mycosis Fungoides After Its Administration. Arch Dermatol. 1977;113(10):1387–1389. doi:10.1001/archderm.1977.01640100065010
Dermatology in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.